US 7368257
Modulators of lymphocyte activation, Mkk3b compositions and methods of use
granted A61KA61K38/00A61K48/00
Quick answer
US patent 7368257 (Modulators of lymphocyte activation, Mkk3b compositions and methods of use) held by Rigel Pharmaceuticals, Inc. expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K48/00